Xiaodi Chen Selected Research

Xiaodi Chen Research Topics

Disease

15	Brain Injuries (Brain Injury) 11/2022 - 01/2013
11	Neoplasms (Cancer) 10/2023 - 08/2003
11	Ischemia 11/2022 - 01/2015
8	Hypoxia (Hypoxemia) 11/2022 - 09/2015
4	Infections 01/2023 - 01/2022
3	Neuralgia (Stump Neuralgia) 01/2020 - 11/2017
2	Pain (Aches) 01/2022 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 10/2021 - 01/2018
2	Neuroinflammatory Diseases 01/2021 - 08/2019
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2008 - 08/2003
2	Colonic Neoplasms (Colon Cancer) 05/2008 - 08/2003
2	Carcinogenesis 01/2007 - 08/2003
1	Wounds and Injuries (Trauma) 05/2024
1	Brain Diseases (Brain Disorder) 05/2024
1	Brain Neoplasms (Brain Tumor) 10/2023
1	Glioblastoma (Glioblastoma Multiforme) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 04/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Congenital torticollis 10/2022
1	Humeral Fractures 06/2022
1	Obesity 01/2022
1	Brain Edema (Cerebral Edema) 01/2022
1	Cerebral Infarction 01/2022
1	Diarrhea 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Atrial Remodeling 01/2022
1	Sepsis (Septicemia) 12/2020
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 12/2020
1	Infarction (Infarctions) 12/2020
1	Inflammation (Inflammations) 01/2020
1	Stroke (Strokes) 01/2019
1	Hypothermia 06/2018
1	Gliosis 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Reperfusion Injury 01/2018
1	Hyperalgesia 11/2017

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 05/2024 - 06/2008
11	inter-alpha-inhibitorIBA 05/2024 - 01/2017
10	CytokinesIBA 01/2021 - 01/2013
5	salicylhydroxamic acid (SHAM)IBA 11/2022 - 01/2015
3	Neuroprotective AgentsIBA 01/2022 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 08/2019 - 08/2003
3	Monoclonal AntibodiesIBA 06/2018 - 01/2015
3	ClusterinIBA 01/2016 - 08/2003
2	CalciumIBA 10/2023 - 08/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2022
2	Ertapenem (Invanz)FDA Link 01/2022 - 01/2022
2	HMGB1 Protein (HMG1)IBA 01/2021 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 11/2017
2	LipidsIBA 01/2020 - 07/2019
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2018
2	Glial Fibrillary Acidic ProteinIBA 08/2019 - 01/2018
2	Neutralizing AntibodiesIBA 01/2018 - 05/2015
2	AntibodiesIBA 01/2017 - 01/2015
2	Tight Junction ProteinsIBA 05/2015 - 01/2015
2	RNA (Ribonucleic Acid)IBA 02/2012 - 06/2008
2	Complementary DNA (cDNA)IBA 05/2008 - 08/2003
2	AntigensIBA 01/2007 - 08/2003
1	Protein Isoforms (Isoforms)IBA 10/2023
1	Peptides (Polypeptides)IBA 10/2023
1	Potassium Channels (Potassium Channel)IBA 10/2023
1	CarcinogensIBA 04/2023
1	Catechol Oxidase (Diphenol Oxidase)IBA 01/2023
1	AcidsIBA 01/2023
1	Malondialdehyde (Propanedial)IBA 01/2023
1	PlacebosIBA 04/2022
1	Claudin-5IBA 04/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	cresyl violetIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	LactamsIBA 01/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2019
1	Peroxidase (Myeloperoxidase)IBA 08/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	progelatinaseIBA 01/2018
1	fluoro jadeIBA 01/2018
1	Myelin Basic ProteinIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	CalcineurinIBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018

Therapy/Procedure

7	Therapeutics 10/2023 - 05/2008
3	Ligation 11/2022 - 01/2019
2	Treatment Delay 12/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2018 - 11/2017
2	Spinal Injections 01/2018 - 11/2017
1	Myotomy 10/2022
1	Osteotomy 06/2022
1	Intravenous Infusions 01/2018